Genewel breaks ground on $67M cGMP plant in Wonju, South Korea

Genewel Co., Ltd. held a groundbreaking ceremony for a new cGMP plant in Wonju, South Korea, with an investment of 50 billion won (approx. $67 million). The facility will produce wound dressings and other medical devices, consolidating existing plants in Seongnam and Hwaseong, and is expected to create 50 new jobs.

“Genewel is investing a total of 50 billion won to build a cGMP plant that meets US FDA standards.”kwnews.co.kr

• 1 source
• kwnews.co.kr창상피복제 '메디폼' 생산 (주)제네웰, 원주공장 시대 예고 - 강원일보May 29, 2025

Summarized from public sources; check the original articles before acting on it.